| Primary |
| Prostate Cancer |
54.2% |
| Breast Cancer |
8.5% |
| Uterine Leiomyoma |
8.5% |
| Depression |
6.8% |
| Chemotherapy |
5.1% |
| Anxiety |
3.4% |
| Endometriosis |
3.4% |
| Prostate Cancer Metastatic |
3.4% |
| Anaemia |
1.7% |
| Cancer Hormonal Therapy |
1.7% |
| Myelodysplastic Syndrome |
1.7% |
| Prostate Cancer Stage 0 |
1.7% |
|
| Death |
15.6% |
| Hypercalcaemia |
12.5% |
| Suicidal Ideation |
9.4% |
| Ataxia |
6.3% |
| Depression |
6.3% |
| Pancytopenia |
6.3% |
| Acute Abdomen |
3.1% |
| Amnesia |
3.1% |
| Chorea |
3.1% |
| Deep Vein Thrombosis |
3.1% |
| Degeneration Of Uterine Fibroid |
3.1% |
| Hepatocellular Injury |
3.1% |
| Macular Degeneration |
3.1% |
| Neutropenia |
3.1% |
| Organising Pneumonia |
3.1% |
| Pharyngeal Abscess |
3.1% |
| Pneumonia |
3.1% |
| Post-traumatic Stress Disorder |
3.1% |
| Pulmonary Embolism |
3.1% |
| Pulmonary Hypoplasia |
3.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
27.7% |
| Breast Cancer |
21.4% |
| Prostate Cancer |
18.8% |
| Breast Cancer Metastatic |
13.4% |
| Chemotherapy |
3.6% |
| Prostate Cancer Metastatic |
3.6% |
| Benign Intracranial Hypertension |
1.8% |
| Bone Pain |
1.8% |
| Metastasis |
1.8% |
| Oestrogen Receptor Assay Positive |
1.8% |
| Prophylaxis |
1.8% |
| Blood Cholesterol Increased |
0.9% |
| Product Used For Unknown Indication |
0.9% |
| Urine Abnormality |
0.9% |
|
| Pulmonary Hypoplasia |
12.9% |
| Multiple Sclerosis Relapse |
9.7% |
| Prostatic Specific Antigen Increased |
9.7% |
| Osteonecrosis |
6.5% |
| Paranoia |
6.5% |
| Urinary Retention |
6.5% |
| Vision Blurred |
6.5% |
| Acute Myeloid Leukaemia |
3.2% |
| Arthralgia |
3.2% |
| Cystoid Macular Oedema |
3.2% |
| Eosinophilic Cystitis |
3.2% |
| Fluid Retention |
3.2% |
| Haematuria |
3.2% |
| Headache |
3.2% |
| Hepatocellular Injury |
3.2% |
| Left Ventricular Dysfunction |
3.2% |
| Liver Injury |
3.2% |
| Metastases To Lung |
3.2% |
| Mood Swings |
3.2% |
| Neuropathy Peripheral |
3.2% |
|
| Concomitant |
| Prostate Cancer |
19.4% |
| Prostate Cancer Metastatic |
16.8% |
| Cancer Pain |
11.5% |
| Hypertension |
8.4% |
| Prophylaxis |
7.8% |
| Hormone Therapy |
5.3% |
| Drug Use For Unknown Indication |
4.3% |
| Metastases To Bone |
3.3% |
| Product Used For Unknown Indication |
3.3% |
| Constipation |
3.0% |
| Diabetes Mellitus |
2.9% |
| Haemoglobin Decreased |
1.9% |
| Nausea |
1.9% |
| Breast Cancer Metastatic |
1.8% |
| Anaemia |
1.7% |
| Pain |
1.5% |
| Back Pain |
1.4% |
| Hypercholesterolaemia |
1.3% |
| Arthralgia |
1.3% |
| Breast Cancer |
1.3% |
|
| Vomiting |
23.4% |
| Renal Failure |
7.8% |
| Osteonecrosis Of Jaw |
6.6% |
| Pneumonia |
6.0% |
| Rhabdomyolysis |
6.0% |
| Transient Ischaemic Attack |
6.0% |
| Blood Creatinine Increased |
5.4% |
| Failure To Thrive |
4.8% |
| Pleural Effusion |
4.2% |
| Hepatic Enzyme Increased |
3.6% |
| Pulmonary Embolism |
3.6% |
| Ischaemic Stroke |
3.0% |
| Weight Decreased |
3.0% |
| Cholecystitis Acute |
2.4% |
| Concussion |
2.4% |
| Disease Progression |
2.4% |
| Encephalopathy |
2.4% |
| Muscle Necrosis |
2.4% |
| Neutropenia |
2.4% |
| Pyrexia |
2.4% |
|
